img

Global T Cell Specific Surface Glycoprotein CD28 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global T Cell Specific Surface Glycoprotein CD28 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

T Cell Specific Surface Glycoprotein CD28 report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global T Cell Specific Surface Glycoprotein CD28 market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Plaque Psoriasis and Solid Tumor are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for T Cell Specific Surface Glycoprotein CD28 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, T Cell Specific Surface Glycoprotein CD28 key manufacturers include Atox Bio Ltd, Bristol-Myers Squibb Co, Five Prime Therapeutics Inc, Johnson & Johnson and TheraMAB LLC, etc. Atox Bio Ltd, Bristol-Myers Squibb Co, Five Prime Therapeutics Inc are top 3 players and held % sales share in total in 2022.
T Cell Specific Surface Glycoprotein CD28 can be divided into FPT-155, FR-104, Lulizumab Pegol and Others, etc. FPT-155 is the mainstream product in the market, accounting for % sales share globally in 2022.
T Cell Specific Surface Glycoprotein CD28 is widely used in various fields, such as Plaque Psoriasis, Solid Tumor, Acute Renal Failure(ARF) and Others, etc. Plaque Psoriasis provides greatest supports to the T Cell Specific Surface Glycoprotein CD28 industry development. In 2022, global % sales of T Cell Specific Surface Glycoprotein CD28 went into Plaque Psoriasis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global T Cell Specific Surface Glycoprotein CD28 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Atox Bio Ltd
Bristol-Myers Squibb Co
Five Prime Therapeutics Inc
Johnson & Johnson
TheraMAB LLC
Segment by Type
FPT-155
FR-104
Lulizumab Pegol
Others

Segment by Application


Plaque Psoriasis
Solid Tumor
Acute Renal Failure(ARF)
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the T Cell Specific Surface Glycoprotein CD28 market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of T Cell Specific Surface Glycoprotein CD28, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the T Cell Specific Surface Glycoprotein CD28 industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of T Cell Specific Surface Glycoprotein CD28 in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, T Cell Specific Surface Glycoprotein CD28 introduction, etc. T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of T Cell Specific Surface Glycoprotein CD28 market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 T Cell Specific Surface Glycoprotein CD28 Market Overview
1.1 T Cell Specific Surface Glycoprotein CD28 Product Overview
1.2 T Cell Specific Surface Glycoprotein CD28 Market Segment by Type
1.2.1 FPT-155
1.2.2 FR-104
1.2.3 Lulizumab Pegol
1.2.4 Others
1.3 Global T Cell Specific Surface Glycoprotein CD28 Market Size by Type
1.3.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size Overview by Type (2018-2034)
1.3.2 Global T Cell Specific Surface Glycoprotein CD28 Historic Market Size Review by Type (2018-2024)
1.3.3 Global T Cell Specific Surface Glycoprotein CD28 Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Type (2018-2024)
1.4.2 Europe T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Type (2018-2024)
1.4.4 Latin America T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Type (2018-2024)
2 Global T Cell Specific Surface Glycoprotein CD28 Market Competition by Company
2.1 Global Top Players by T Cell Specific Surface Glycoprotein CD28 Sales (2018-2024)
2.2 Global Top Players by T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2024)
2.3 Global Top Players by T Cell Specific Surface Glycoprotein CD28 Price (2018-2024)
2.4 Global Top Manufacturers T Cell Specific Surface Glycoprotein CD28 Manufacturing Base Distribution, Sales Area, Product Type
2.5 T Cell Specific Surface Glycoprotein CD28 Market Competitive Situation and Trends
2.5.1 T Cell Specific Surface Glycoprotein CD28 Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by T Cell Specific Surface Glycoprotein CD28 Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in T Cell Specific Surface Glycoprotein CD28 as of 2022)
2.7 Date of Key Manufacturers Enter into T Cell Specific Surface Glycoprotein CD28 Market
2.8 Key Manufacturers T Cell Specific Surface Glycoprotein CD28 Product Offered
2.9 Mergers & Acquisitions, Expansion
3 T Cell Specific Surface Glycoprotein CD28 Status and Outlook by Region
3.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global T Cell Specific Surface Glycoprotein CD28 Historic Market Size by Region
3.2.1 Global T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Region (2018-2024)
3.2.2 Global T Cell Specific Surface Glycoprotein CD28 Sales in Value by Region (2018-2024)
3.2.3 Global T Cell Specific Surface Glycoprotein CD28 Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global T Cell Specific Surface Glycoprotein CD28 Forecasted Market Size by Region
3.3.1 Global T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Region (2024-2034)
3.3.2 Global T Cell Specific Surface Glycoprotein CD28 Sales in Value by Region (2024-2034)
3.3.3 Global T Cell Specific Surface Glycoprotein CD28 Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global T Cell Specific Surface Glycoprotein CD28 by Application
4.1 T Cell Specific Surface Glycoprotein CD28 Market Segment by Application
4.1.1 Plaque Psoriasis
4.1.2 Solid Tumor
4.1.3 Acute Renal Failure(ARF)
4.1.4 Others
4.2 Global T Cell Specific Surface Glycoprotein CD28 Market Size by Application
4.2.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size Overview by Application (2018-2034)
4.2.2 Global T Cell Specific Surface Glycoprotein CD28 Historic Market Size Review by Application (2018-2024)
4.2.3 Global T Cell Specific Surface Glycoprotein CD28 Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Application (2018-2024)
4.3.2 Europe T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Application (2018-2024)
4.3.4 Latin America T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Application (2018-2024)
5 North America T Cell Specific Surface Glycoprotein CD28 by Country
5.1 North America T Cell Specific Surface Glycoprotein CD28 Historic Market Size by Country
5.1.1 North America T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Country (2018-2024)
5.1.3 North America T Cell Specific Surface Glycoprotein CD28 Sales in Value by Country (2018-2024)
5.2 North America T Cell Specific Surface Glycoprotein CD28 Forecasted Market Size by Country
5.2.1 North America T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Country (2024-2034)
5.2.2 North America T Cell Specific Surface Glycoprotein CD28 Sales in Value by Country (2024-2034)
6 Europe T Cell Specific Surface Glycoprotein CD28 by Country
6.1 Europe T Cell Specific Surface Glycoprotein CD28 Historic Market Size by Country
6.1.1 Europe T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Country (2018-2024)
6.1.3 Europe T Cell Specific Surface Glycoprotein CD28 Sales in Value by Country (2018-2024)
6.2 Europe T Cell Specific Surface Glycoprotein CD28 Forecasted Market Size by Country
6.2.1 Europe T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Country (2024-2034)
6.2.2 Europe T Cell Specific Surface Glycoprotein CD28 Sales in Value by Country (2024-2034)
7 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 by Region
7.1 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Historic Market Size by Region
7.1.1 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales in Value by Region (2018-2024)
7.2 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Forecasted Market Size by Region
7.2.1 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales in Value by Region (2024-2034)
8 Latin America T Cell Specific Surface Glycoprotein CD28 by Country
8.1 Latin America T Cell Specific Surface Glycoprotein CD28 Historic Market Size by Country
8.1.1 Latin America T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Country (2018-2024)
8.1.3 Latin America T Cell Specific Surface Glycoprotein CD28 Sales in Value by Country (2018-2024)
8.2 Latin America T Cell Specific Surface Glycoprotein CD28 Forecasted Market Size by Country
8.2.1 Latin America T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Country (2024-2034)
8.2.2 Latin America T Cell Specific Surface Glycoprotein CD28 Sales in Value by Country (2024-2034)
9 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 by Country
9.1 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Historic Market Size by Country
9.1.1 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales in Value by Country (2018-2024)
9.2 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Forecasted Market Size by Country
9.2.1 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Atox Bio Ltd
10.1.1 Atox Bio Ltd Company Information
10.1.2 Atox Bio Ltd Introduction and Business Overview
10.1.3 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Products Offered
10.1.5 Atox Bio Ltd Recent Development
10.2 Bristol-Myers Squibb Co
10.2.1 Bristol-Myers Squibb Co Company Information
10.2.2 Bristol-Myers Squibb Co Introduction and Business Overview
10.2.3 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Products Offered
10.2.5 Bristol-Myers Squibb Co Recent Development
10.3 Five Prime Therapeutics Inc
10.3.1 Five Prime Therapeutics Inc Company Information
10.3.2 Five Prime Therapeutics Inc Introduction and Business Overview
10.3.3 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Products Offered
10.3.5 Five Prime Therapeutics Inc Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 TheraMAB LLC
10.5.1 TheraMAB LLC Company Information
10.5.2 TheraMAB LLC Introduction and Business Overview
10.5.3 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales, Revenue and Gross Margin (2018-2024)
10.5.4 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Products Offered
10.5.5 TheraMAB LLC Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 T Cell Specific Surface Glycoprotein CD28 Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 T Cell Specific Surface Glycoprotein CD28 Industrial Chain Analysis
11.4 T Cell Specific Surface Glycoprotein CD28 Market Dynamics
11.4.1 T Cell Specific Surface Glycoprotein CD28 Industry Trends
11.4.2 T Cell Specific Surface Glycoprotein CD28 Market Drivers
11.4.3 T Cell Specific Surface Glycoprotein CD28 Market Challenges
11.4.4 T Cell Specific Surface Glycoprotein CD28 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 T Cell Specific Surface Glycoprotein CD28 Distributors
12.3 T Cell Specific Surface Glycoprotein CD28 Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of FPT-155
Table 2. Major Company of FR-104
Table 3. Major Company of Lulizumab Pegol
Table 4. Major Company of Others
Table 5. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2018-2024) & (K Pcs)
Table 7. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Type (2018-2024)
Table 8. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2018-2024) & (US& Million)
Table 9. Global T Cell Specific Surface Glycoprotein CD28 Market Share in Value by Type (2018-2024)
Table 10. Global T Cell Specific Surface Glycoprotein CD28 Price by Type (2018-2024) & (USD/Pcs)
Table 11. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2024-2034) & (K Pcs)
Table 12. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Type (2024-2034)
Table 13. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2024-2034) & (US$ Million)
Table 14. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Type (2024-2034)
Table 15. Global T Cell Specific Surface Glycoprotein CD28 Price by Type (2024-2034) & (USD/Pcs)
Table 16. North America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2018-2024) & (K Pcs)
Table 17. North America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs) by Type (2018-2024)
Table 19. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs) by Type (2018-2024)
Table 21. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs) by Type (2018-2024)
Table 23. Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs) by Type (2018-2024)
Table 25. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Type (2018-2024) & (US$ Million)
Table 26. Global T Cell Specific Surface Glycoprotein CD28 Sales by Company (2018-2024) & (K Pcs)
Table 27. Global T Cell Specific Surface Glycoprotein CD28 Sales Share by Company (2018-2024)
Table 28. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global T Cell Specific Surface Glycoprotein CD28 Revenue Share by Company (2018-2024)
Table 30. Global Market T Cell Specific Surface Glycoprotein CD28 Price by Company (2018-2024) & (USD/Pcs)
Table 31. Global T Cell Specific Surface Glycoprotein CD28 Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global T Cell Specific Surface Glycoprotein CD28 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in T Cell Specific Surface Glycoprotein CD28 as of 2022)
Table 34. Date of Key Manufacturers Enter into T Cell Specific Surface Glycoprotein CD28 Market
Table 35. Key Manufacturers T Cell Specific Surface Glycoprotein CD28 Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global T Cell Specific Surface Glycoprotein CD28 Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global T Cell Specific Surface Glycoprotein CD28 Sales by Region (2018-2024) & (K Pcs)
Table 39. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Region (2018-2024)
Table 40. Global T Cell Specific Surface Glycoprotein CD28 Sales by Region (2018-2024) & (US$ Million)
Table 41. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Region (2018-2024)
Table 42. Global T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 43. Global T Cell Specific Surface Glycoprotein CD28 Sales by Region (2024-2034) & (K Pcs)
Table 44. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Region (2024-2034)
Table 45. Global T Cell Specific Surface Glycoprotein CD28 Sales by Region (2024-2034) & (US$ Million)
Table 46. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Region (2024-2034)
Table 47. Global T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 48. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2018-2024) & (K Pcs)
Table 50. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Application (2018-2024)
Table 51. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2018-2024) & (US$ Million)
Table 52. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Application (2018-2024)
Table 53. Global T Cell Specific Surface Glycoprotein CD28 Price by Application (2018-2024) & (USD/Pcs)
Table 54. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2024-2034) & (K Pcs)
Table 55. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Application (2024-2034)
Table 56. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2024-2034) & (US$ Million)
Table 57. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Application (2024-2034)
Table 58. Global T Cell Specific Surface Glycoprotein CD28 Price by Application (2024-2034) & (USD/Pcs)
Table 59. North America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2018-2024) (K Pcs)
Table 60. North America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Application (2018-2024) (K Pcs)
Table 62. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Application (2018-2024) (K Pcs)
Table 64. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2018-2024) (K Pcs)
Table 66. Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Application (2018-2024) (K Pcs)
Table 68. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Application (2018-2024) & (US$ Million)
Table 69. North America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2018-2024) & (K Pcs)
Table 70. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Country (2018-2024)
Table 71. North America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2018-2024) & (US$ Million)
Table 72. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Country (2018-2024)
Table 73. North America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2024-2034) & (K Pcs)
Table 74. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Country (2024-2034)
Table 75. North America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2024-2034) & (US$ Million)
Table 76. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Country (2024-2034)
Table 77. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country (2018-2024) & (K Pcs)
Table 78. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Country (2018-2024)
Table 81. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country (2024-2034) & (K Pcs)
Table 82. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Region (2018-2024) & (K Pcs)
Table 86. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Region (2024-2034) & (K Pcs)
Table 90. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2018-2024) & (K Pcs)
Table 94. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2024-2034) & (K Pcs)
Table 98. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Country (2018-2024) & (K Pcs)
Table 102. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Country (2024-2034) & (K Pcs)
Table 106. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Country (2024-2034)
Table 109. Atox Bio Ltd Company Information
Table 110. Atox Bio Ltd Introduction and Business Overview
Table 111. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Product
Table 113. Atox Bio Ltd Recent Development
Table 114. Bristol-Myers Squibb Co Company Information
Table 115. Bristol-Myers Squibb Co Introduction and Business Overview
Table 116. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Product
Table 118. Bristol-Myers Squibb Co Recent Development
Table 119. Five Prime Therapeutics Inc Company Information
Table 120. Five Prime Therapeutics Inc Introduction and Business Overview
Table 121. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Product
Table 123. Five Prime Therapeutics Inc Recent Development
Table 124. Johnson & Johnson Company Information
Table 125. Johnson & Johnson Introduction and Business Overview
Table 126. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Product
Table 128. Johnson & Johnson Recent Development
Table 129. TheraMAB LLC Company Information
Table 130. TheraMAB LLC Introduction and Business Overview
Table 131. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Product
Table 133. TheraMAB LLC Recent Development
Table 134. Key Raw Materials Lists
Table 135. Raw Materials Key Suppliers Lists
Table 136. T Cell Specific Surface Glycoprotein CD28 Market Trends
Table 137. T Cell Specific Surface Glycoprotein CD28 Market Drivers
Table 138. T Cell Specific Surface Glycoprotein CD28 Market Challenges
Table 139. T Cell Specific Surface Glycoprotein CD28 Market Restraints
Table 140. T Cell Specific Surface Glycoprotein CD28 Distributors List
Table 141. T Cell Specific Surface Glycoprotein CD28 Downstream Customers
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. T Cell Specific Surface Glycoprotein CD28 Product Picture
Figure 2. Global T Cell Specific Surface Glycoprotein CD28 Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global T Cell Specific Surface Glycoprotein CD28 Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global T Cell Specific Surface Glycoprotein CD28 Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of FPT-155
Figure 6. Global FPT-155 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of FR-104
Figure 8. Global FR-104 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Lulizumab Pegol
Figure 10. Global Lulizumab Pegol Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type in 2022 & 2034
Figure 15. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Type in 2022
Figure 16. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Type in 2022
Figure 17. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Type in 2022
Figure 18. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Type in 2022
Figure 21. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Type in 2022
Figure 22. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by T Cell Specific Surface Glycoprotein CD28 Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by T Cell Specific Surface Glycoprotein CD28 Revenue in 2022
Figure 27. T Cell Specific Surface Glycoprotein CD28 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Plaque Psoriasis
Figure 29. Global Plaque Psoriasis Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Solid Tumor
Figure 31. Global Solid Tumor Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Acute Renal Failure(ARF)
Figure 33. Global Acute Renal Failure(ARF) Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application in 2022 & 2034
Figure 38. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Application in 2022
Figure 39. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Application in 2022
Figure 40. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Application in 2022
Figure 41. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Application in 2022
Figure 44. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Application in 2022
Figure 45. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. T Cell Specific Surface Glycoprotein CD28 Manufacturing Cost Structure
Figure 49. T Cell Specific Surface Glycoprotein CD28 Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed